MedTrace Logo

HOPE-Epilepsy Trial

NCT01744275 · Status: SUSPENDED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 370

Last updated 2014-02-27

No results posted yet for this study

Summary

This a multi-center study to examine whether supplementation with omega 3 fatty acids will reduce seizure frequency in patients with epilepsy .

Conditions

Interventions

DIETARY_SUPPLEMENT

Omega 3 fatty acids

DIETARY_SUPPLEMENT

corn oil

Placebo

Sponsors & Collaborators

  • Hospital do Coracao

    lead OTHER

Principal Investigators

  • M J Carrion, MD · Hospital do Coracao

  • O Berwanger, PhD · Hospital do Coracao

  • R D Lopes, PhD · BCRI

  • F A Scorza, PhD · Federal University of São Paulo

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2014-07-31
Completion
2016-07-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01744275 on ClinicalTrials.gov